Details for Patent: 10,517,880
✉ Email this page to a colleague
Which drugs does patent 10,517,880 protect, and when does it expire?
Patent 10,517,880 protects RYALTRIS and is included in one NDA.
This patent has seventy-three patent family members in twenty-eight countries.
Summary for Patent: 10,517,880
| Title: | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| Abstract: | The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject. |
| Inventor(s): | Dhuppad; Ulhas R. (Maharashtra, IN), Katkurwar; Ashok (Maharashtra, IN), Gupta; Yashwant (Maharashtra, IN), Ankam; Rajesh (Maharashtra, IN), Dhatrak; Chandrakant (Maharashtra, IN) |
| Assignee: | GLENMARK SPECIALTY S.A. (La Chaux-de-Fonds, CH) |
| Application Number: | 15/703,801 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
More… ↓ |
Drugs Protected by US Patent 10,517,880
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Speclt | RYALTRIS | mometasone furoate; olopatadine hydrochloride | SPRAY, METERED;NASAL | 211746-001 | Jan 13, 2022 | RX | Yes | Yes | 10,517,880 | ⤷ Subscribe | Y | TREATMENT OF SEASONAL ALLERGIC RHINITIS BY NASALY ADMINISTERING A COMBINATION OF OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,517,880
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| India | 2975/MUM/2013 | Sep 13, 2013 |
International Family Members for US Patent 10,517,880
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3043773 | ⤷ Subscribe | CA 2021 00050 | Denmark | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | 301154 | Netherlands | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | 122021000085 | Germany | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | 132021000000191 | Italy | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | 57/2021 | Austria | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | 2022C/520 | Belgium | ⤷ Subscribe |
| European Patent Office | 3043773 | ⤷ Subscribe | C202130060 | Spain | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
